Trade Summary

2 days ago, BJERKHOLT ERIC, serving as CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 5,000 shares at $93.82 per share, for a total transaction value of $469,077.01. Following this transaction, BJERKHOLT ERIC now holds 44,788 shares of MIRM.

This sale represents a 10.04% decrease in BJERKHOLT ERIC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 8, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 10, 2026 (accepted Jun 9, 9:21 PM ET), 2 days after the trade was made.

Mirum Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.